Trials / Completed
CompletedNCT00043784
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting With Acute Coronary Syndromes (ACS)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 8,000 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients experiencing a mild heart attack will receive one of two medications which thin the blood to discern which is superior.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | enoxaparin |
Timeline
- Start date
- 2001-08-01
- Primary completion
- 2005-02-01
- First posted
- 2002-08-15
- Last updated
- 2008-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00043784. Inclusion in this directory is not an endorsement.